Revolutionary Immunotherapy Shows Promise for Treatment-Resistant Depression

A groundbreaking clinical trial spearheaded by the University of Bristol has unveiled a potential paradigm shift in the treatment of severe and persistent depression, offering a new avenue for millions…

Unlocking Ketamine’s Secrets: New PET Imaging Reveals Brain Receptor Dynamics in Treatment-Resistant Depression

Major depressive disorder (MDD) continues to cast a long shadow over global public health, recognized as a significant contributor to disability worldwide. For a substantial portion of individuals diagnosed with…